Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richert E Goyette

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 30, 2005
The science of megestrol acetate delivery: potential to improve outcomes in cachexiaRobert A Femia, Richert E Goyette
The Mount Sinai Journal of Medicine, New York|December 15, 2012
Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?Jonathan L Halperin, Richert E Goyette
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 12, 2013
Oral anticoagulation therapy for elderly patients with atrial fibrillation: utility of bleeding risk covariates to better understand and moderate risksDaniel E Forman, Richert E Goyette
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|March 11, 2003
Advances in the understanding of clinical manifestations and therapy of severe sepsis: an update for critical care nursesE Wesley Ely, Ruth M Kleinpell, Richert E Goyette
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Hematologic changes in sepsis and their therapeutic implicationsRichert E Goyette, Nigel S Key, E Wesley Ely
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 30, 2005
The science of megestrol acetate delivery: potential to improve outcomes in cachexiaRobert A Femia, Richert E Goyette
The Mount Sinai Journal of Medicine, New York|December 15, 2012
Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?Jonathan L Halperin, Richert E Goyette
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 12, 2013
Oral anticoagulation therapy for elderly patients with atrial fibrillation: utility of bleeding risk covariates to better understand and moderate risksDaniel E Forman, Richert E Goyette
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|March 11, 2003
Advances in the understanding of clinical manifestations and therapy of severe sepsis: an update for critical care nursesE Wesley Ely, Ruth M Kleinpell, Richert E Goyette
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Hematologic changes in sepsis and their therapeutic implicationsRichert E Goyette, Nigel S Key, E Wesley Ely
Pageof 1